The Impact of Pastured Livestock Food Consumption on Fatty Acid and Metabolomic Profiles
1 other identifier
interventional
80
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the effects of consuming meat and eggs from regenerative/pastured versus conventional farming practices on health biomarkers in middle-aged adults. The main questions it aims to answer are: How does consumption of pastured animal products influence red blood cell omega-3 fatty acid levels, inflammatory markers, and metabolomic profiles compared to conventional animal products? What are the potential metabolic health benefits or risks associated with consuming animal products from regenerative farming practices? Researchers will compare participants consuming pastured meat and eggs to those consuming conventional meat and eggs to determine differences in health outcomes. Participants will: Consume study-provided chicken thighs, ground beef, ground pork, and eggs for 16 weeks. Attend clinic visits for blood, urine, and stool sample collection before and after the intervention. Complete dietary assessments to monitor compliance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2025
CompletedFirst Posted
Study publicly available on registry
January 10, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 21, 2025
CompletedOctober 28, 2025
October 1, 2025
7 months
January 6, 2025
October 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Red Blood Cell (RBC) Omega-3 Fatty Acid Levels
Assessment of changes in red blood cell omega-3 fatty acid composition as a marker of cardiovascular health. Blood samples will be collected at baseline and after the 16-week intervention to measure levels using gas chromatography-mass spectrometry (GC and LC/MS).
Baseline and 16 weeks (end of intervention).
Secondary Outcomes (1)
Metabolomics Profile Analysis
Baseline to Week 16 (End of Study)
Study Arms (2)
Pastured Livestock Products Group
EXPERIMENTALParticipants in this group will consume meat and eggs sourced from regenerative/pastured farming practices. Weekly allocations include chicken (300-500g), beef (500-700g), pork (300-500g), and 8-12 eggs, depending on the habitual caloric intake of participants. These products are provided for the 16-week intervention, with adherence monitored through dietary logs and 24-hour recalls.
Conventional Livestock Products Group
EXPERIMENTALParticipants in this group will consume meat and eggs sourced from conventional farming practices. Weekly allocations include chicken (300-500g), beef (500-700g), pork (300-500g), and 8-12 eggs, depending on the habitual caloric intake of participants. These products are provided for the 16-week intervention, with adherence monitored through dietary logs and 24-hour recalls.
Interventions
Participants will consume a diet consisting of animal-source foods (chicken, beef, pork, and eggs) from regenerative/pastured farming practices. Foods will be provided weekly in specific quantities for a 16-week intervention. Adherence will be monitored through dietary logs and ASA24 dietary assessments.
Participants will consume a diet consisting of animal-source foods (chicken, ground, pork, and eggs) from conventional farming practices. Foods will be provided weekly in specific quantities for a 16-week intervention. Adherence will be monitored through dietary logs and ASA24 dietary assessments.
Eligibility Criteria
You may qualify if:
- Age between 30 and 65 years. BMI between 25 and 35 kg/m². Weight stability within the last three months (loss or gain \< 4%). Hemoglobin A1C (HbA1C) ≤ 6.4%. Fasting plasma glucose concentration \< 126 mg/dL. Ability to understand and communicate in English or Spanish.
You may not qualify if:
- Use of medications known to affect study outcomes (e.g., NSAIDs, corticosteroids, anticoagulants) that cannot be discontinued temporarily.
- Blood pressure ≥ 140/90 mmHg without physician clearance. Unwillingness to forgo seafood consumption or omega-3 supplement intake during the study.
- Alcohol consumption \> 14 drinks per week. Tobacco product use within the last three months. Receipt of a COVID vaccine within the last two weeks. Engagement in high-level competitive exercise (e.g., triathlon, marathon, powerlifting).
- Diagnosed inflammatory diseases (e.g., autoimmune disorders, coeliac disease, arthritis).
- Diagnoses of active malignancy, congestive heart failure, diabetes mellitus, or chronic obstructive pulmonary disease.
- Use of antibiotics within the last 60 days. Pregnancy or planning pregnancy within the next month. Lactating women. Allergies to meat or eggs. Inability or unwillingness to comply with the study protocol, including adherence to study visits and dietary requirements.
- Dietary preferences that exclude meat or eggs (e.g., vegan, vegetarian, halal). Any condition that, in the opinion of the research team, makes the participant unsuitable for the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Human Nutrition Studies
Logan, Utah, 84341, United States
Related Publications (1)
McAfee AJ, McSorley EM, Cuskelly GJ, Fearon AM, Moss BW, Beattie JA, Wallace JM, Bonham MP, Strain JJ. Red meat from animals offered a grass diet increases plasma and platelet n-3 PUFA in healthy consumers. Br J Nutr. 2011 Jan;105(1):80-9. doi: 10.1017/S0007114510003090.
PMID: 20807460BACKGROUND
Related Links
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 6, 2025
First Posted
January 10, 2025
Study Start
March 1, 2025
Primary Completion
September 21, 2025
Study Completion
September 21, 2025
Last Updated
October 28, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR, ANALYTIC CODE
Decoded metabolomics data will be shared through public repositories such as Metabolomics Workbench to ensure accessibility. Decoded data on inflammatory biomarkers, gut microbiome profiles, and bloodwork results will be included as supplemental information in peer-reviewed publications resulting from this study.